drugset / Trial / NCT02854670

A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia

NCT02854670

Phase 2/3 Terminated 10 enrolled Centre Hospitalier Universitaire de Besancon
NaSingle-groupOpen-labelTreatment

Summary

This study aims to assess the pain on contact in provoked vestibulodynia, measured with Visual Analogic Scale at week 0/week 2/week 6/week 12 after applying a patch of capsaicin.

Timeline

Start
2016-01-20
Primary completion
2021-02-03
Completion
2021-02-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 2.5 mg Topical

Indications